Sustained Response to Healthcare Challenges Through Revenue Diversification
First written in FY2019. 3 of 7 entries say "Advanced", first in FY2023-Q3. Latest entry: FY2026-H1.
0 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「In addition, the automated payment machine for clinics “TEMASAC®,” which is being developed as a new business, has been steadily increasing its contracts. 株式会社オルシード's next-generation waste-processing machine “Low-Temperature Pyrolysis Upcycle Unit OLSTECH®,” established on 6 January 2025, is also steadily laying the groundwork for future market expansion.」
Regarding revenue diversification, contracts for automated payment machines for clinics are increasing, while 株式会社オルシード is preparing to launch OLSTECH in the market. - FY2025-H1AdvancedAnnual report
「In addition, 株式会社オルシード, which was established on 6 January 2025 as a new business, will begin selling the next-generation waste-processing machine “Low-Temperature Pyrolysis Upcycle Unit OLSTECH,” developed to help realize a sustainable society through an environmentally responsible circular economy. Alongside sales of automated payment machines for clinics, which have been steadily increasing in unit sales, the company will work to expand sales of equipment and fixtures in the second half of the fiscal year.」
Regarding revenue diversification, the company has progressed to the stage of expanding its automated payment machines for clinics and establishing 株式会社オルシード to begin selling environmentally responsible next-generation waste-processing machines. - FY2024RestatedAnnual report
「③ Investment in the future: Key priorities include nurturing new businesses, promoting external partnerships, and ensuring sustainability. We will establish a business base in Thailand, expand Kawanishi Barkmed's clinic-focused business, promote business partnerships both inside and outside the industry, invest in human capital, and pursue initiatives that take the global environment into consideration.」
The company continues to pursue revenue diversification as part of its “investment in the future,” including Thailand, its clinic-focused business, external partnerships, and investment in human capital and the environment. - FY2023-Q3AdvancedAnnual report
「In addition, for the purpose of selling medical equipment mainly in Thailand, we entered into a JOINT BUSINESS AGREEMENT on 26 January 2023 with Thai individual shareholders concerning a joint investment in and operation of THAI OLBA Healthcare Co., Ltd. (formerly Medical Device Innovation Co., Ltd.), and commenced the joint venture business.」
As a specific measure to diversify its revenue sources, the company launched a joint venture to sell medical equipment in Thailand. - FY2022RaisedAnnual report
「④ Exploring new businesses: To diversify revenue sources, we will explore opportunities to expand into ASEAN countries, expand the clinic-focused business of カワニシバークメド, and promote medical-engineering collaboration with manufacturing companies.」
The company added ASEAN expansion, Kawanishi Barkmed's clinic-focused business, and medical-engineering collaboration with manufacturing companies as specific areas to explore in diversifying its revenue sources. - FY2020RestatedAnnual report
「Establishing a framework capable of continuously addressing various healthcare challenges by diversifying revenue sources through new business development」
The company continues to diversify its revenue sources through new business development as a means of establishing a framework for continuously addressing healthcare challenges. - FY2019First statedAnnual report
「① Establishing a business structure capable of addressing a wide range of healthcare issues on a sustainable basis by diversifying revenue sources」
The company has explicitly identified, for the first time as the first item in its medium- to long-term policy, the establishment of a framework for continuously addressing various healthcare challenges by diversifying its revenue sources.